Arginaz inhibitörleri ve kullanım yöntemleri
Mevcut buluş, Formül IA veya Formül IB arginaz inhibitör bileşikleri: veya farmasötik olarak kabul edilebilir bir tuzu, bu bileşikler içeren mevcut bileşimler ve arginazın yukarı regülasyonu, anormal olarak yüksek arginaz etkinliği veya anormal şekilde düşük nitrik oksit sentaz etkinliği ile karakte...
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | tur |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | RICHARD SCOTT, POTTORF ANDREW VARGHA, COLASANTI BRUCE EDWARD, TOMCZUK DAVID W., CHRISTIANSON GARY LEE, OLSON |
| description | Mevcut buluş, Formül IA veya Formül IB arginaz inhibitör bileşikleri: veya farmasötik olarak kabul edilebilir bir tuzu, bu bileşikler içeren mevcut bileşimler ve arginazın yukarı regülasyonu, anormal olarak yüksek arginaz etkinliği veya anormal şekilde düşük nitrik oksit sentaz etkinliği ile karakterize olan durumların tedavisi ve teşhisi için kullanım yöntemlerine yöneliktir.
or a pharmaceutically acceptable salt thereof, compositions containing these compounds, and methods of their use for the treatment and diagnosis of conditions characterized by upregulation of arginase, abnormally high arginase activity, or by abnormally low nitric oxide synthase activity. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TR201910726TT4</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TR201910726TT4</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TR201910726TT43</originalsourceid><addsrcrecordid>eNrjZNB3LErPzEusUsjMy8hMyiw5vK0oJ7UoU6EsVSG7NCcnMe_IxlyFysPb8kpSc0ESPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPiTIyMDQ0tDA3MgsJMTEmDhVAPxqLtI</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Arginaz inhibitörleri ve kullanım yöntemleri</title><source>esp@cenet</source><creator>RICHARD SCOTT, POTTORF ; ANDREW VARGHA, COLASANTI ; BRUCE EDWARD, TOMCZUK ; DAVID W., CHRISTIANSON ; GARY LEE, OLSON</creator><creatorcontrib>RICHARD SCOTT, POTTORF ; ANDREW VARGHA, COLASANTI ; BRUCE EDWARD, TOMCZUK ; DAVID W., CHRISTIANSON ; GARY LEE, OLSON</creatorcontrib><description>Mevcut buluş, Formül IA veya Formül IB arginaz inhibitör bileşikleri: veya farmasötik olarak kabul edilebilir bir tuzu, bu bileşikler içeren mevcut bileşimler ve arginazın yukarı regülasyonu, anormal olarak yüksek arginaz etkinliği veya anormal şekilde düşük nitrik oksit sentaz etkinliği ile karakterize olan durumların tedavisi ve teşhisi için kullanım yöntemlerine yöneliktir.
or a pharmaceutically acceptable salt thereof, compositions containing these compounds, and methods of their use for the treatment and diagnosis of conditions characterized by upregulation of arginase, abnormally high arginase activity, or by abnormally low nitric oxide synthase activity.</description><language>tur</language><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS ; ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM ; CHEMISTRY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2019</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190821&DB=EPODOC&CC=TR&NR=201910726T4$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20190821&DB=EPODOC&CC=TR&NR=201910726T4$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>RICHARD SCOTT, POTTORF</creatorcontrib><creatorcontrib>ANDREW VARGHA, COLASANTI</creatorcontrib><creatorcontrib>BRUCE EDWARD, TOMCZUK</creatorcontrib><creatorcontrib>DAVID W., CHRISTIANSON</creatorcontrib><creatorcontrib>GARY LEE, OLSON</creatorcontrib><title>Arginaz inhibitörleri ve kullanım yöntemleri</title><description>Mevcut buluş, Formül IA veya Formül IB arginaz inhibitör bileşikleri: veya farmasötik olarak kabul edilebilir bir tuzu, bu bileşikler içeren mevcut bileşimler ve arginazın yukarı regülasyonu, anormal olarak yüksek arginaz etkinliği veya anormal şekilde düşük nitrik oksit sentaz etkinliği ile karakterize olan durumların tedavisi ve teşhisi için kullanım yöntemlerine yöneliktir.
or a pharmaceutically acceptable salt thereof, compositions containing these compounds, and methods of their use for the treatment and diagnosis of conditions characterized by upregulation of arginase, abnormally high arginase activity, or by abnormally low nitric oxide synthase activity.</description><subject>ACYCLIC OR CARBOCYCLIC COMPOUNDS</subject><subject>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</subject><subject>CHEMISTRY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2019</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZNB3LErPzEusUsjMy8hMyiw5vK0oJ7UoU6EsVSG7NCcnMe_IxlyFysPb8kpSc0ESPAysaYk5xam8UJqbQdnNNcTZQze1ID8-tbggMTk1L7UkPiTIyMDQ0tDA3MgsJMTEmDhVAPxqLtI</recordid><startdate>20190821</startdate><enddate>20190821</enddate><creator>RICHARD SCOTT, POTTORF</creator><creator>ANDREW VARGHA, COLASANTI</creator><creator>BRUCE EDWARD, TOMCZUK</creator><creator>DAVID W., CHRISTIANSON</creator><creator>GARY LEE, OLSON</creator><scope>EVB</scope></search><sort><creationdate>20190821</creationdate><title>Arginaz inhibitörleri ve kullanım yöntemleri</title><author>RICHARD SCOTT, POTTORF ; ANDREW VARGHA, COLASANTI ; BRUCE EDWARD, TOMCZUK ; DAVID W., CHRISTIANSON ; GARY LEE, OLSON</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TR201910726TT43</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>tur</language><creationdate>2019</creationdate><topic>ACYCLIC OR CARBOCYCLIC COMPOUNDS</topic><topic>ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM</topic><topic>CHEMISTRY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>RICHARD SCOTT, POTTORF</creatorcontrib><creatorcontrib>ANDREW VARGHA, COLASANTI</creatorcontrib><creatorcontrib>BRUCE EDWARD, TOMCZUK</creatorcontrib><creatorcontrib>DAVID W., CHRISTIANSON</creatorcontrib><creatorcontrib>GARY LEE, OLSON</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>RICHARD SCOTT, POTTORF</au><au>ANDREW VARGHA, COLASANTI</au><au>BRUCE EDWARD, TOMCZUK</au><au>DAVID W., CHRISTIANSON</au><au>GARY LEE, OLSON</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Arginaz inhibitörleri ve kullanım yöntemleri</title><date>2019-08-21</date><risdate>2019</risdate><abstract>Mevcut buluş, Formül IA veya Formül IB arginaz inhibitör bileşikleri: veya farmasötik olarak kabul edilebilir bir tuzu, bu bileşikler içeren mevcut bileşimler ve arginazın yukarı regülasyonu, anormal olarak yüksek arginaz etkinliği veya anormal şekilde düşük nitrik oksit sentaz etkinliği ile karakterize olan durumların tedavisi ve teşhisi için kullanım yöntemlerine yöneliktir.
or a pharmaceutically acceptable salt thereof, compositions containing these compounds, and methods of their use for the treatment and diagnosis of conditions characterized by upregulation of arginase, abnormally high arginase activity, or by abnormally low nitric oxide synthase activity.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | tur |
| recordid | cdi_epo_espacenet_TR201910726TT4 |
| source | esp@cenet |
| subjects | ACYCLIC OR CARBOCYCLIC COMPOUNDS ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAININGELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN,SULFUR, SELENIUM OR TELLURIUM CHEMISTRY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | Arginaz inhibitörleri ve kullanım yöntemleri |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-29T11%3A14%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=RICHARD%20SCOTT,%20POTTORF&rft.date=2019-08-21&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETR201910726TT4%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |